Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Organon India names Vivek Soares as new Country Lead for India, South Asia

Ruchika Sharma4 Jun 2024 10:30 AM IST

New Delhi: Organon India has announced the appointment of Vivek Soares as its new Country Lead for India and South Asia, commencing on June ...

Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio

Tata Capital arm injects USD 20 million in Orbicular Pharmaceutical Technologies

Ruchika Sharma3 Jun 2024 4:06 PM IST

Tata Capital Healthcare Fund II, an arm of Tata Capital has injected USD 20 million in Orbicular Pharmaceutical Technologies for an...

CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab Trial

GSK disagrees with ruling by Delaware State Court on ranitidine litigation, to seek appeal

Ruchika Sharma3 Jun 2024 2:41 PM IST

London: GSK plc has announced that it disagrees with the ruling by the Delaware State Court and will immediately seek an appeal. The decision by...

Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan

Lupin bags USFDA tentative nod for Letermovir Tablets

Ruchika Sharma3 Jun 2024 1:30 PM IST

Mumbai: Global pharma major Lupin Limited today announced that the Company has received a tentative approval from the United States Food and Drug...

Aurobindo Pharma in lead to acquire Zentiva for US 5.5 billion: ET Report

Aurobindo Pharma unit partners with MSD to foray into contract manufacturing operations

Ruchika Sharma3 Jun 2024 12:42 PM IST

Hyderabad: Drug firm, Aurobindo Pharma has said that TheraNym Biologics, a wholly-owned subsidiary of the Company and an affiliate of...

Sun Pharma Gets CDSCO Panel Nod for Phase IV Trial of Esomeprazole Dual Release Tablets 80 mg

Sun Pharma anticipates high single-digit top line growth in current fiscal: Dilip Shanghvi

Ruchika Sharma3 Jun 2024 11:53 AM IST

New Delhi: Sun Pharmaceutical Industries, a leading pharmaceutical company, anticipates achieving a robust single-digit top line increase in...

Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag International

Johnson & Johnson concludes acquisition of Shockwave Medical

Ruchika Sharma2 Jun 2024 3:31 PM IST

New Brunswick: Johnson & Johnson has announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson &...

Moderna gets USFDA nod for mRNA RSV vaccine

Ruchika Sharma2 Jun 2024 1:30 PM IST

Cambridge: Moderna, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory...

Royalty Pharma to buy royalty interest in Amgen Imdelltra for up to USD 950 million

Sanofi concludes acquisition of Inhibrx

Ruchika Sharma2 Jun 2024 11:00 AM IST

Paris: Sanofi has announced the completion of its acquisition of Inhibrx, Inc. The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s...

Sanofi Wayrilz wins USFDA approval for adults with immune thrombocytopenia

Sanofi-Regeneron Dupixent recommended for EU approval by CHMP to treat COPD patients

Ruchika Sharma1 Jun 2024 3:33 PM IST

Paris: Sanofi and Regeneron have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has...

Johnson & Johnson Executive Vice President William N Hait to retire

Ruchika Sharma1 Jun 2024 2:15 PM IST

New Brunswick: Johnson & Johnson has announced that William N. (Bill) Hait, M.D., Ph.D., will retire from his position as Executive Vice...

AbbVie seeks USFDA nod for combination regimen of Venclexta, Acalabrutinib

USFDA grants priority review to Merck application for Keytruda plus chemotherapy for Metastatic Malignant Pleural Mesothelioma

Ruchika Sharma1 Jun 2024 12:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok